Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Lara Laini"'
Autor:
Rebecca Pedersini, Pierluigi di Mauro, Vito Amoroso, Vincenza Castronovo, Manuel Zamparini, Sara Monteverdi, Lara Laini, Greta Schivardi, Deborah Cosentini, Salvatore Grisanti, Sara Marelli, Luigi Ferini Strambi, Alfredo Berruti
Publikováno v:
Breast, Vol 66, Iss , Pp 162-168 (2022)
Introduction: Whether adjuvant therapy with aromatase inhibitors (AIs) causes sleep disturbances or not in postmenopausal women with early breast cancer (EBC) is still a controversial issue. Methods: Between March 2014 and November 2017, validated qu
Externí odkaz:
https://doaj.org/article/99cd9dfa477048b8bb7ce1056066d7d3
Autor:
Rebecca Pedersini, Deborah Cosentini, Luca Rinaudo, Manuel Zamparini, Fabio Massimo Ulivieri, Pierluigi di Mauro, Filippo Maffezzoni, Sara Monteverdi, Walter Vena, Lara Laini, Vito Amoroso, Edda Lucia Simoncini, Davide Farina, Gherardo Mazziotti, Alfredo Berruti
Publikováno v:
Bone Reports, Vol 18, Iss , Pp 101654- (2023)
Background: Bone mineral density (BMD) lacks sensitivity in individual fracture risk assessment in early breast cancer (EBC) patients treated with aromatase inhibitors (AIs). New dual-energy X-ray absorptiometry (DXA) based risk factors are needed. M
Externí odkaz:
https://doaj.org/article/ba248560d4cc46be9270b812a4d5b509
Autor:
Pierluigi di Mauro, Greta Schivardi, Rebecca Pedersini, Lara Laini, Andrea Esposito, Vito Amoroso, Marta Laganà, Salvatore Grisanti, Deborah Cosentini, Alfredo Berruti
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundTriple-negative breast cancer (TNBC) is an aggressive cancer subtype, owing to its high metastatic potential: Patients who develop brain metastases (BMs) have a poor prognosis due to the lack of effective systemic treatments. Surgery and ra
Externí odkaz:
https://doaj.org/article/3cf7983c09e8463db74984731e41047e
Autor:
Andrea Alberti, Davide Smussi, Manuel Zamparini, Antonella Turla, Lara Laini, Chiara Marchiselli, Salvatore Grisanti, Paolo Bossi, Alfredo Berruti
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundParathyroid carcinoma (PC) is an extremely rare malignant tumor with an incidence of about 6 new cases per 10 million inhabitants per year. While several papers have been published on treatments and outcomes of PC patients with loco-regiona
Externí odkaz:
https://doaj.org/article/571fc75e9f744c78bf858f2388ca253d
Autor:
Walter Vena, Rebecca Pedersini, Deborah Cosentini, Luca Rinaudo, Manuel Zamparini, Ulivieri Fabio Massimo, Pierluigi Di Mauro, Filippo Maffezzoni, Sara Monteverdi, Lara Laini, Vito Amoroso, Simoncini Edda Lucia, Davide Farina, Lania Andre Gerardo, Alfredo Berruti, Gherardo Mazziotti
Publikováno v:
Endocrine Abstracts.
Autor:
Pierluigi di Mauro, Rebecca Pedersini, Fausto Petrelli, Antonio Ghidini, Vito Amoroso, Lara Laini, Maria Chiara Parati, Paolo Bossi, Alfredo Berruti
Publikováno v:
Cancer Research. 82:P5-18
Introduction. Antibody-drug conjugates (ADCs) represent a new class of molecular-targeted drugs, which are being developed to selectively target tumor cells and minimize toxicities. Three ADCs, namely trastuzumab emtansine (TDM-1), sacituzumab govite